Elucidation of the etiology and characteristics of pink urine in young healthy subjects

Clinical and Experimental Nephrology

Volumn 19, Issue 5, 2015, Pages 822-829

  Ogawa, Susumu ^a,b   Takiguchi, Junko ^b   Nako, Kazuhiro ^a   Okamura, Masashi ^a   Sakamoto, Takuya ^a   Kabayama, Shigeru ^c   Mori, Takefumi ^a   Kinouchi, Yoshitaka ^b   Ito, Sadayoshi ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c Trim Medical Institute Co Ltd   (Japan)

Author keywords

Angiotensinogen; Methylglyoxal; Oxidative stress; Pink urine syndrome; Urinary pH

Indexed keywords

ANGIOTENSINOGEN; C PEPTIDE; METHYLGLYOXAL; SODIUM; THIOBARBITURIC ACID REACTIVE SUBSTANCE; URIC ACID;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHRONIC KIDNEY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PINK URINE SYNDROME; PROTEINURIA; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINARY TRACT DISEASE; URINE PH; WAIST CIRCUMFERENCE; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; COLOR; COMPLICATION; METABOLISM; PH; RISK FACTOR; SYNDROME; URINE; UROLOGIC DISEASES; YOUNG ADULT;

ADOLESCENT; ANGIOTENSINOGEN; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BODY MASS INDEX; COLOR; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; OBESITY; PYRUVALDEHYDE; RISK FACTORS; SYNDROME; THIOBARBITURIC ACID REACTIVE SUBSTANCES; URIC ACID; UROLOGIC DISEASES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84944174452     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-014-1066-y     Document Type: Article

References (29)

1. Deitel M, Thompson DA, Saldanha CF, Ramshaw PJ, Patterson MC, Pritzker KP. “Pink urine” in morbidly obese patients following gastric partitioning. Can Med Assoc J. 1984;130:1007–11.
2. Saran R, Abdullah S, Goel S, Nolph KD, Terry BE. An unusual cause of pink urine. Nephrol Dial Transpl. 1998;13:1579–80.
3. Scialla JJ, Anderson CA. Dietary acid load: a novel nutritional target in chronic kidney disease? Adv Chronic Kidney Dis. 2013;20:141–9.
4. Adeva MM, Souto G. Diet-induced metabolic acidosis. Clin Nutr. 2011;30:416–21.
5. Miyazawa N, Abe M, Souma T, Tanemoto M, Abe T, Nakayama M, Ito S. Methylglyoxal augments intracellular oxidative stress in human aortic endothelial cells. Free Radic Res. 2010;44:101–7.
6. Gaens KH, Stehouwer CD, Schalkwijk CG. Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity. Curr Opin Lipidol. 2013;24:4–11.
7. Ogawa S, Kobori H, Ohashi N, Urushihara M, Nishiyama A, Mori T, Ishizuka T, Nako K, Ito S. Angiotensin II type 1 receptor blockers reduce urinary angiotensinogen excretion and the levels of urinary markers of oxidative stress and inflammation in patients with Type 2 diabetic nephropathy. Biomark Insights. 2009;4:97–102.
8. Dhar I, Dhar A, Wu L, Desai KM. Increased methylglyoxal formation with upregulation of renin angiotensin system in fructose fed Sprague Dawley rats. PLoS One. 2013;8:e74212.
9. Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H, Hashimoto T. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16:97–103.
10. Azuma K, Minami Y, Ippoushi K, Terao J. Lowering effects of onion intake on oxidative stress biomarkers in streptozotocin-induced diabetic rats. J Clin Biochem Nutr. 2007;40:131–40.
11. Ogawa S, Nakayama K, Nakayama M, Mori T, Matsushima M, Okamura M, Senda M, Nako K, Miyata T, Ito S. Methylglyoxal is a predictor in type 2 diabetic patients of intima-media thickening and elevation of blood pressure. Hypertension. 2010;56:471–6.
12. Zuckerman JM, Assimos DG. Hypocitraturia: pathophysiology and medical management. Rev Urol. 2009;11:134–44.
13. Krupp D, Shi L, Remer T. Longitudinal relationships between diet-dependent renal acid load and blood pressure development in healthy children. Kidney Int. 2014;85:204–10.
14. Goraya N, Simoni J, Jo CH, Wesson DE. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol. 2013;8:371–81.
15. Mandel EI, Taylor EN, Curhan GC. Dietary and lifestyle factors and medical conditions associated with urinary citrate excretion. Clin J Am Soc Nephrol. 2013;8:901–8.
16. Otsuki M, Kitamura T, Goya K, Saito H, Mukai M, Kasayama S, Shimomura I, Koga M. Association of urine acidification with visceral obesity and the metabolic syndrome. Endocr J. 2011;58:363–7.
17. Archibeque SL, Freetly HC, Cole NA, Ferrell CL. The influence of oscillating dietary protein concentrations on finishing cattle. II. Nutrient retention and ammonia emissions. J Anim Sci. 2007;85:1496–503.
18. + exchanger in renal cells. Am J Physiol Ren Physiol. 2013;305:F370–81.
19. Odani H, Shinzato T, Matsumoto Y, Usami J, Maeda K. Increase in three alpha, beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction. Biochem Biophys Res Commun. 1999;256:89–93.
20. Chang T, Wu L. Methylglyoxal, oxidative stress, and hypertension. Can J Physiol Pharmacol. 2006;84:1229–38.
21. Guo Q, Mori T, Jiang Y, Hu C, Osaki Y, Yoneki Y, Sun Y, Hosoya T, Kawamata A, Ogawa S, Nakayama M, Miyata T, Ito S. Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats. J Hypertens. 2009;27:1664–71.
22. Wang X, Jia X, Chang T, Desai K, Wu L. Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats. J Hypertens. 2008;26:765–72.
23. Gekle M, Knaus P, Nielsen R, Mildenberger S, Freudinger R, Wohlfarth V, Sauvant C, Christensen EI. Transforming growth factor-beta1 reduces megalin- and cubilin-mediated endocytosis of albumin in proximal-tubule-derived opossum kidney cells. J Physiol. 2003;552:471–81.
24. Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells. Kidney Int. 2003;63:464–73.
25. Saito A, Takeda T, Sato K, Hama H, Tanuma A, Kaseda R, Suzuki Y, Gejyo F. Significance of proximal tubular metabolism of advanced glycation end products in kidney diseases. Ann NY Acad Sci. 2005;1043:637–43.
26. Ozdemir AM, Hopfer U, Rosca MV, Fan XJ, Monnier VM, Weiss MF. Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin. Am J Nephrol. 2008;28:14–24.
27. + exchanger isoform NHE3 in the proximal tubule. J Biol Chem. 1999;274:17518–24.
28. Li XC, Hopfer U, Zhuo JL. AT1 receptor-mediated uptake of angiotensin II and NHE-3 expression in proximal tubule cells through a microtubule-dependent endocytic pathway. Am J Physiol Ren Physiol. 2009;297:F1342–52.
29. Hosojima M, Sato H, Yamamoto K, Kaseda R, Soma T, Kobayashi A, Suzuki A, Kabasawa H, Takeyama A, Ikuyama K, Iino N, Nishiyama A, Thekkumkara TJ, Takeda T, Suzuki Y, Gejyo F, Saito A. Regulation of megalin expression in cultured proximal tubule cells by angiotensin II type 1A receptor- and insulin-mediated signaling cross talk. Endocrinology. 2009;150:871–8.